IGF-1LR3

IGF-1 LR3, a synthetic insulin-like growth factor variant, represents an advanced research compound engineered to extend biological half-life compared to native IGF-1. This modified peptide maintains structural integrity through enhanced receptor binding affinity, making it a subject of interest in cellular research and regenerative studies. The LR3 designation indicates the addition of an arginine residue and extension of the N-terminus, optimizing stability and duration of action. Utilized primarily in laboratory and clinical research settings, IGF-1 LR3 demonstrates potential applications in muscle tissue development, metabolic function, and recovery protocols. This compound requires proper handling and storage protocols to maintain efficacy and is intended exclusively for research purposes by qualified professionals.